Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/13/25
End: 05/30/27
Due: 05/30/28
Phase: N/A
Priority: Normal
Start: 03/13/19
End: 05/21/20
Due: 05/21/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer | NCT06736379 | VLP Therapeutics | user2@example.com | None | 2025-05-13 | 2027-05-30 | 2028-05-30 | - | - | 2025-07-14 |
| To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers | NCT03867331 | VLP Therapeutics | user2@example.com | None | 2019-03-13 | 2020-05-21 | 2021-05-21 | - | - | 2025-07-14 |